Today: 11 June 2026
T-Mobile (TMUS) stock sinks to a 52-week low range — what to watch before Tuesday’s reopen
17 January 2026
1 min read

T-Mobile (TMUS) stock sinks to a 52-week low range — what to watch before Tuesday’s reopen

New York, Jan 17, 2026, 16:32 EST — Market closed.

  • TMUS dropped 2.28% on Friday, closing at $186.32 after hitting a low of $185.18, the bottom of its 52-week range.
  • T-Mobile highlighted a fresh J.D. Power network-quality award, yet its stock has faltered ahead of a packed schedule of upcoming catalysts.
  • Investors are focused on the Jan. 21 fee step-up and the company’s earnings and targets update due Feb. 11.

T-Mobile US Inc shares slipped 2.28% on Friday, ending the day at $186.32. The stock hit a session low of $185.18, brushing the bottom of its 52-week range amid a tough day for U.S. telecom stocks.

U.S. stock markets were closed Monday for Martin Luther King Jr. Day. As trading resumes Tuesday, stocks face fresh technical pressure with limited time before key company-specific events.

T-Mobile plans to release its fourth-quarter and full-year 2025 results on Feb. 11. The company will also hold a Capital Markets Day update in New York that day, unveiling updated financial targets for 2026 and 2027, it said.

Looking closer, T-Mobile’s support site reveals its “Regulatory Programs & Telco Recovery Fee” will increase starting Jan. 21 — rising to $4.49 per month on voice lines, up from $3.99, and to $2.10 on mobile internet lines, up from $1.60. The company stresses this is not a government tax but a fee it collects and keeps to cover certain expenses. T-Mobile

T-Mobile has been emphasizing its performance. On Jan. 15, it announced that customers ranked it highest for network quality in five out of six U.S. regions, according to the J.D. Power 2026 U.S. Wireless Network Quality Study. John Saw, T-Mobile’s president and chief technology officer, described the accolade as “meaningful,” highlighting that it reflects customers’ everyday experience. T-Mobile

Wall Street remains cautious. On Friday, Bernstein’s Laurent Yoon kept a “Market Perform” rating on T-Mobile but lowered his price target to $245 from $265, according to a summary on GuruFocus. (A price target reflects where brokers expect a stock to trade within a year.) GuruFocus

T-Mobile’s shares slid as the sector struggled. Verizon dropped 1.14%, and AT&T lost 1.01% on Friday. The S&P 500 also finished modestly lower, per MarketWatch data.

Promotions have returned to the spotlight. Metro by T-Mobile recently launched new switching deals, featuring an unlimited plan priced at $25 a month for customers who bring their own device. It’s a clear sign that pricing still plays a major role in the wireless market.

The near-term outlook is mixed. Should customers resist higher line-item fees or promotions escalate into a price war, investors could start fretting over churn, margins, and just how much pricing power carriers actually hold this year.

Tuesday’s open will have traders eyeing whether TMUS stays above Friday’s low and if any new analyst calls come in after the drop. After that, attention shifts to the Jan. 21 fee change, with T-Mobile’s Feb. 11 earnings and targets update looming further ahead.

Stock Market Today

  • Ford Stock Down 6% Over Five Years Amid Strategic Shift
    June 11, 2026, 10:58 AM EDT. Ford's stock has fallen 6% over five years, significantly underperforming the S&P 500's 71% gain despite a recent 20% rally. The company exited costly electric vehicle (EV) programs, launching Ford Energy to produce lithium-ion phosphate batteries for energy storage through a partnership with China's CATL. Investors remain cautious, focusing on Ford's reliance on domestic sales of its F-Series gas-powered trucks, its longstanding best-seller. Ford's strategic pivot away from EVs, admitting Chinese EV competition risks, and modest international presence contribute to lingering investor skepticism about its long-term value.

Latest articles

Theriva Biologics Pops on VCN-01 Study Results, Gets Traders’ Attention

Theriva Biologics Pops on VCN-01 Study Results, Gets Traders’ Attention

11 June 2026
TOVX soared 74.6% to $0.4252 after Theriva Biologics published Phase 1 VCN-01 data showing survival and biomarker signals in head-and-neck cancer, but the jump was not due to drug approval or revenue; investors face ongoing financing, dilution, and clinical-trial execution risks, with the company’s cash runway only into Q1 2027 and substantial doubt about its ability to continue as a going concern without new capital.
Trulieve Stock Turns Heads on NYSE After $50 Million Buyback

Trulieve Stock Turns Heads on NYSE After $50 Million Buyback

11 June 2026
Trulieve began NYSE trading as TRLV this week after moving from OTC/CSE, authorized a buyback of up to $50 million or 8.5 million shares, and closed its first NYSE session at $11.50, down 0.43%, before trading near $11.78 early Thursday, as investors weigh whether the uplisting and buyback will boost demand amid ongoing federal cannabis policy uncertainty.
Propanc Biopharma Jumps on $5 Million Buyback Plan, Investors React

Propanc Biopharma Jumps on $5 Million Buyback Plan, Investors React

11 June 2026
Propanc Biopharma shares soared as much as 392% after authorizing up to $5 million in stock buybacks—exceeding its prior $3.1 million equity value—even as it reported just $443,702 in cash and flagged going-concern risks, with investors now focused on whether its lead cancer drug PRP will advance to a planned Phase 1b trial this year.
IREN stock jumps 11% on analyst upgrade chatter — what matters before Nasdaq reopens
Previous Story

IREN stock jumps 11% on analyst upgrade chatter — what matters before Nasdaq reopens

MediaTek stock price: Taiwan chip designer closes higher as AI trade lifts sentiment — what to watch next
Next Story

MediaTek stock price: Taiwan chip designer closes higher as AI trade lifts sentiment — what to watch next

Go toTop